In NPC, platelet-derived extracellular vesicles (EVs) enriched in integrin β3 (ITGB3) transferred this integrin into tumor cells, activating the MAPK/ERK/ATF4/Nrf2 axis [31]. The gene discussed is ATF4; the disease is nasopharyngeal carcinoma.